News
10-24-2007, 09:40 PM
Mayo Clinic has reported promising interim results from a Phase II trial of a new combination therapy for patients with recurrent ovarian cancer that is resistant to platinum therapy.
More... (http://www.news-medical.net/?id=31655)
More... (http://www.news-medical.net/?id=31655)